CARBIDOPA AND LEVODOPA

CARBIDOPA AND LEVODOPA was reported 47271 times

CARBIDOPA AND LEVODOPA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEEP BRAIN STIMULATION 197 0.3262
1 FREEZING PHENOMENON 947 0.2555
2 STOMA SITE IRRITATION 135 0.2482
3 STOMA SITE INFECTION 299 0.2296
4 STOMA SITE DISCHARGE 616 0.2248
5 STOMA SITE ERYTHEMA 410 0.2193
6 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 105 0.2104
7 STOMA SITE HYPERGRANULATION 129 0.2044
8 ON AND OFF PHENOMENON 1113 0.2003
9 STOMA SITE PAIN 293 0.1993
10 STOMA SITE ODOUR 42 0.1875
11 CATHETER SITE NODULE 34 0.1780
12 STOMA SITE INDURATION 21 0.1765
13 STOMA SITE DISCOMFORT 39 0.1718
14 STOMA SITE REACTION 115 0.1679
15 DOPAMINE DYSREGULATION SYNDROME 74 0.1659
16 STOMA SITE EXTRAVASATION 61 0.1580
17 PARKINSONISM HYPERPYREXIA SYNDROME 26 0.1453
18 CATHETER SITE INDURATION 28 0.1451
19 DEVICE COLOUR ISSUE 58 0.1436
20 BENIGN NEOPLASM OF ADRENAL GLAND 21 0.1400
21 PATHOLOGICAL GAMBLING 223 0.1343
22 STOMA SITE OEDEMA 28 0.1279
23 MEDICAL DEVICE CHANGE 67 0.1257
24 SALIVA DISCOLOURATION 41 0.1228
25 STOMA SITE HAEMORRHAGE 183 0.1188
26 PARKINSON'S DISEASE 297 0.1167
27 JEALOUS DELUSION 33 0.1166
28 DRUG EFFECT VARIABLE 128 0.1130
29 VITAMIN B6 DEFICIENCY 27 0.1098
30 STOMA COMPLICATION 107 0.1053
31 DEVICE ALARM ISSUE 187 0.1029
32 REDUCED FACIAL EXPRESSION 102 0.1005
33 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 37 0.0920
34 LIVING IN RESIDENTIAL INSTITUTION 171 0.0911
35 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 90 0.0894
36 MULTIPLE SYSTEM ATROPHY 31 0.0881
37 STOMA SITE INFLAMMATION 65 0.0870
38 BRADYKINESIA 466 0.0789
39 DEVICE PROGRAMMING ERROR 24 0.0757
40 DYSKINESIA 3072 0.0755
41 THERAPEUTIC PRODUCT EFFECT VARIABLE 288 0.0742
42 HYPERSEXUALITY 131 0.0716
43 EUTHANASIA 22 0.0694
44 ENTERAL NUTRITION 40 0.0690
45 PATIENT ELOPEMENT 25 0.0683
46 DEMENTIA WITH LEWY BODIES 75 0.0674
47 PARKINSONIAN GAIT 42 0.0673
48 DEVICE KINK 241 0.0661
49 REHABILITATION THERAPY 256 0.0660
50 YAWNING 165 0.0618
51 DEVICE CONNECTION ISSUE 129 0.0611
52 CATHETER SITE BRUISE 20 0.0604
53 BLOOD PRESSURE ORTHOSTATIC DECREASED 20 0.0588
54 COMPULSIONS 38 0.0571
55 FIBROMA 52 0.0566
56 DEVICE LOOSENING 48 0.0555
57 HALLUCINATION 4027 0.0534
58 MUSCLE RIGIDITY 619 0.0517
59 IMPULSE-CONTROL DISORDER 106 0.0515
60 HYPERKINESIA 105 0.0495
61 PRODUCT RESIDUE PRESENT 264 0.0489
62 DEVICE OCCLUSION 683 0.0485
63 DELUSION 753 0.0484
64 AKINESIA 99 0.0478
65 SLEEP ATTACKS 22 0.0462
66 GAMBLING 51 0.0437
67 INFUSION SITE CELLULITIS 23 0.0436
68 POSTURE ABNORMAL 139 0.0427
69 HALLUCINATION, VISUAL 885 0.0419
70 SUSPICIOUSNESS 29 0.0413
71 COMPULSIVE SHOPPING 84 0.0408
72 LIBIDO INCREASED 80 0.0394
73 HALLUCINATION, TACTILE 26 0.0390
74 SALIVA ALTERED 35 0.0389
75 RESTING TREMOR 24 0.0372
76 SUDDEN ONSET OF SLEEP 51 0.0367
77 NONSPECIFIC REACTION 199 0.0362
78 DELUSIONAL DISORDER, UNSPECIFIED TYPE 27 0.0361
79 FEAR OF FALLING 28 0.0343
80 HOSPICE CARE 333 0.0337
81 INFUSION SITE NODULE 31 0.0323
82 HALLUCINATIONS, MIXED 131 0.0311
83 SLEEP TALKING 52 0.0306
84 DEVICE DAMAGE 24 0.0301
85 PRESCRIBED OVERDOSE 577 0.0298
86 CATHETER SITE RELATED REACTION 22 0.0293
87 BLADDER CATHETERISATION 28 0.0289
88 DRUG EFFECT DELAYED 124 0.0273
89 THERAPEUTIC RESPONSE SHORTENED 904 0.0272
90 OBSESSIVE-COMPULSIVE DISORDER 209 0.0260
91 GASTROSTOMY 40 0.0258
92 DROOLING 177 0.0256
93 DYSTONIA 481 0.0248
94 DEMENTIA 674 0.0241
95 COGWHEEL RIGIDITY 25 0.0238
96 BEZOAR 32 0.0232
97 DEVICE DISLOCATION 994 0.0228
98 THERAPEUTIC PRODUCT EFFECT DELAYED 102 0.0223
99 INFUSION SITE MASS 24 0.0221
100 UTERINE PROLAPSE 24 0.0221
101 INTENTIONAL UNDERDOSE 160 0.0219
102 ORTHOSTATIC HYPOTENSION 380 0.0218
103 INFUSION SITE IRRITATION 28 0.0218
104 FINE MOTOR SKILL DYSFUNCTION 62 0.0214
105 HYPOKINESIA 310 0.0213
106 DYSGRAPHIA 140 0.0212
107 PARKINSONISM 207 0.0212
108 IMPULSIVE BEHAVIOUR 78 0.0208
109 CATHETER SITE DISCHARGE 23 0.0205
110 NASAL DISCHARGE DISCOLOURATION 28 0.0203
111 TREMOR 3359 0.0202
112 TENSION 114 0.0187
113 PARANOIA 319 0.0185
114 COMMUNICATION DISORDER 70 0.0183
115 FLUID INTAKE REDUCED 91 0.0182
116 GAMBLING DISORDER 49 0.0181
117 SLOW SPEECH 44 0.0181
118 CATHETER SITE ERYTHEMA 38 0.0177
119 INFUSION SITE INDURATION 26 0.0175
120 STARING 41 0.0169
121 IMMOBILE 73 0.0167
122 INFUSION SITE BRUISING 36 0.0167
123 ILLUSION 27 0.0163
124 GAIT INABILITY 543 0.0162
125 SPEECH DISORDER 844 0.0161
126 GASTROINTESTINAL TUBE INSERTION 40 0.0160
127 PNEUMONIA ASPIRATION 393 0.0157
128 HIP FRACTURE 500 0.0155
129 DEVICE ISSUE 1373 0.0153
130 CHOREA 26 0.0151
131 NOCTURIA 183 0.0151
132 DEVICE POWER SOURCE ISSUE 44 0.0151
133 INFUSION SITE INFECTION 35 0.0150
134 MEDICAL DEVICE DISCOMFORT 46 0.0150
135 PALLIATIVE CARE 23 0.0150
136 MEDICAL DEVICE IMPLANTATION 23 0.0146
137 WHEELCHAIR USER 65 0.0146
138 MEDICAL DEVICE REMOVAL 25 0.0145
139 CATHETER SITE PAIN 37 0.0142
140 MOVEMENT DISORDER 457 0.0142
141 PRODUCT PACKAGING DIFFICULT TO OPEN 37 0.0142
142 TERMINAL INSOMNIA 25 0.0141
143 ABNORMAL DREAMS 389 0.0141
144 DYSCHEZIA 43 0.0141
145 ABNORMAL BEHAVIOUR 558 0.0141
146 FAECALOMA 77 0.0140
147 GASTROINTESTINAL STOMA COMPLICATION 22 0.0140
148 DEVICE USE ISSUE 243 0.0139
149 AORTIC VALVE INCOMPETENCE 59 0.0139
150 BALANCE DISORDER 1191 0.0138
151 FALL 4554 0.0137
152 CONFUSIONAL STATE 2195 0.0136
153 DYSSTASIA 388 0.0133
154 MEDICAL PROCEDURE 22 0.0132
155 PRESCRIBED UNDERDOSE 263 0.0132
156 CHOKING 255 0.0131
157 DEVICE PHYSICAL PROPERTY ISSUE 100 0.0130
158 HYPERPHAGIA 52 0.0130
159 DECUBITUS ULCER 106 0.0130
160 PERSECUTORY DELUSION 32 0.0128
161 APRAXIA 19 0.0128
162 BEHAVIOUR DISORDER 69 0.0127
163 TERMINAL STATE 85 0.0127
164 PSYCHOTIC DISORDER 369 0.0125
165 PNEUMOPERITONEUM 23 0.0124
166 HYPOPHAGIA 316 0.0123
167 VOLVULUS 29 0.0122
168 UNRESPONSIVE TO STIMULI 314 0.0122
169 VITAMIN B12 DECREASED 35 0.0121
170 RESTLESS LEGS SYNDROME 220 0.0121
171 CLAVICLE FRACTURE 46 0.0120
172 PRODUCT CLEANING INADEQUATE 32 0.0120
173 SKIN LACERATION 130 0.0119
174 SLEEP TERROR 50 0.0119
175 UNINTENTIONAL MEDICAL DEVICE REMOVAL 137 0.0118
176 SALIVARY HYPERSECRETION 118 0.0118
177 FAILURE TO THRIVE 61 0.0117
178 PROSTATOMEGALY 46 0.0117
179 MEDICAL DEVICE PAIN 25 0.0117
180 DRUG EFFECT LESS THAN EXPECTED 172 0.0116
181 ASPIRATION 127 0.0116
182 CERVICAL VERTEBRAL FRACTURE 40 0.0116
183 IMPAIRED SELF-CARE 24 0.0116
184 SUBILEUS 24 0.0115
185 EMBEDDED DEVICE 113 0.0114
186 INFUSION SITE REACTION 34 0.0114
187 FOOD INTERACTION 20 0.0113
188 HEAD INJURY 358 0.0113
189 MOBILITY DECREASED 811 0.0113
190 COGNITIVE DISORDER 525 0.0112
191 MOTOR DYSFUNCTION 114 0.0112
192 BRADYPHRENIA 73 0.0112
193 HYPERSOMNIA 319 0.0111
194 INCOHERENT 72 0.0111
195 AGGRESSION 553 0.0110
196 CATATONIA 58 0.0110
197 NEUROLEPTIC MALIGNANT SYNDROME 131 0.0110
198 SCREAMING 70 0.0110
199 GAIT DISTURBANCE 2071 0.0108
200 INCONTINENCE 113 0.0107
201 EMERGENCY CARE 32 0.0105
202 CEREBRAL ATROPHY 42 0.0105
203 DIZZINESS POSTURAL 102 0.0105
204 DEVICE MATERIAL ISSUE 22 0.0105
205 MASTICATION DISORDER 32 0.0104
206 INFREQUENT BOWEL MOVEMENTS 26 0.0104
207 BLOOD SODIUM INCREASED 28 0.0104
208 TORTICOLLIS 22 0.0104
209 NIGHTMARE 358 0.0103
210 METABOLIC ENCEPHALOPATHY 31 0.0103
211 FACE INJURY 39 0.0103
212 MUSCULOSKELETAL STIFFNESS 896 0.0102
213 SOMNOLENCE 2043 0.0101
214 DYSPHAGIA 957 0.0101
215 LIVEDO RETICULARIS 21 0.0100
216 SPUTUM DISCOLOURED 95 0.0100
217 ADVERSE EVENT 911 0.0099
218 DRUG EFFECT INCOMPLETE 358 0.0098
219 AGITATION 720 0.0098
220 FAECES HARD 38 0.0098
221 HALLUCINATION, AUDITORY 155 0.0097
222 DISORIENTATION 386 0.0097
223 INFUSION SITE ERYTHEMA 82 0.0097
224 PRE-EXISTING CONDITION IMPROVED 60 0.0096
225 DELIRIUM 329 0.0095
226 RIB FRACTURE 194 0.0094
227 WALKING AID USER 62 0.0094
228 PSYCHOMOTOR HYPERACTIVITY 156 0.0094
229 SPINAL STENOSIS 38 0.0092
230 HYPERVENTILATION 53 0.0091
231 BLOOD PRESSURE FLUCTUATION 219 0.0091
232 URINARY TRACT INFECTION 1535 0.0090
233 MIDDLE INSOMNIA 168 0.0090
234 DEVICE PLACEMENT ISSUE 32 0.0089
235 POOR QUALITY SLEEP 190 0.0088
236 LOGORRHOEA 31 0.0088
237 RESTLESSNESS 319 0.0087
238 TRISMUS 45 0.0087
239 INITIAL INSOMNIA 89 0.0087
240 BEDRIDDEN 114 0.0087
241 DYSPHEMIA 38 0.0087
242 HYPERTONIC BLADDER 25 0.0086
243 SLUGGISHNESS 88 0.0086
244 APHASIA 260 0.0086
245 AUTONOMIC NERVOUS SYSTEM IMBALANCE 25 0.0085
246 FRUSTRATION TOLERANCE DECREASED 68 0.0084
247 CATHETER SITE HAEMORRHAGE 21 0.0084
248 BOWEL MOVEMENT IRREGULARITY 64 0.0083
249 DECREASED INTEREST 49 0.0083
250 THERAPY CESSATION 425 0.0083
251 COMPLICATION ASSOCIATED WITH DEVICE 120 0.0083
252 ANAESTHETIC COMPLICATION 22 0.0082
253 PRODUCT USE COMPLAINT 129 0.0082
254 ABNORMAL FAECES 67 0.0082
255 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 392 0.0082
256 CHOKING SENSATION 45 0.0082
257 HYPOPNOEA 28 0.0081
258 HAND FRACTURE 57 0.0080
259 BRUXISM 43 0.0080
260 DYSARTHRIA 298 0.0079
261 LUMBAR SPINAL STENOSIS 23 0.0079
262 DEVICE BREAKAGE 318 0.0078
263 ANAL INCONTINENCE 70 0.0078
264 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 553 0.0078
265 HIP SURGERY 42 0.0078
266 FEEDING DISORDER 156 0.0077
267 SKIN ABRASION 36 0.0076
268 BLOOD PRESSURE DECREASED 506 0.0076
269 LISTLESS 25 0.0076
270 PELVIC FRACTURE 59 0.0076
271 BENIGN PROSTATIC HYPERPLASIA 39 0.0075
272 NEGATIVE THOUGHTS 22 0.0075
273 GENERAL SYMPTOM 56 0.0075
274 WEIGHT BEARING DIFFICULTY 20 0.0074
275 BLOOD CHLORIDE DECREASED 19 0.0074
276 MICTURITION URGENCY 84 0.0073
277 DEVICE LEAKAGE 317 0.0073
278 UNEVALUABLE EVENT 549 0.0072
279 INFUSION SITE SWELLING 45 0.0071
280 URINARY INCONTINENCE 209 0.0070
281 INFUSION SITE HAEMORRHAGE 23 0.0070
282 MALNUTRITION 78 0.0070
283 TRICUSPID VALVE INCOMPETENCE 55 0.0069
284 PERSONALITY CHANGE 64 0.0069
285 ANXIETY DISORDER 23 0.0069
286 CHOLECYSTITIS INFECTIVE 19 0.0068
287 SPINAL OPERATION 84 0.0068
288 WRIST FRACTURE 81 0.0068
289 SOPOR 89 0.0067
290 SOMNAMBULISM 44 0.0067
291 FACIAL BONES FRACTURE 24 0.0067
292 THERAPEUTIC PRODUCT EFFECT DECREASED 298 0.0066
293 ENERGY INCREASED 39 0.0066
294 FEELING DRUNK 49 0.0066
295 INTENTIONAL DEVICE MISUSE 29 0.0066
296 MUSCLE TIGHTNESS 106 0.0065
297 GASTROINTESTINAL MOTILITY DISORDER 35 0.0065
298 STUPOR 21 0.0065
299 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 112 0.0065
300 UROSEPSIS 60 0.0065
301 CONSTIPATION 1408 0.0064
302 MANIA 106 0.0064
303 MUSCLE TWITCHING 148 0.0064
304 DIFFICULTY IN WALKING 22 0.0064
305 DIPLOPIA 166 0.0064
306 THINKING ABNORMAL 119 0.0064
307 DRY MOUTH 512 0.0063
308 FEMORAL NECK FRACTURE 32 0.0062
309 PANIC DISORDER 24 0.0062
310 MALABSORPTION 32 0.0061
311 BLOOD PRESSURE ABNORMAL 121 0.0061
312 CATHETER SITE INFECTION 23 0.0061
313 PRODUCT DISPENSING ISSUE 26 0.0061
314 MEMORY IMPAIRMENT 835 0.0061
315 BLADDER DISORDER 60 0.0060
316 LOSS OF CONSCIOUSNESS 763 0.0059
317 EATING DISORDER 126 0.0059
318 SLEEP DISORDER 416 0.0059
319 LETHARGY 339 0.0059
320 FEELING JITTERY 112 0.0059
321 MENTAL STATUS CHANGES 162 0.0058
322 PANIC REACTION 42 0.0058
323 HEAD DISCOMFORT 103 0.0058
324 TEARFULNESS 25 0.0058
325 PRODUCT PHYSICAL ISSUE 117 0.0058
326 LACERATION 54 0.0057
327 DEVICE DIFFICULT TO USE 378 0.0057
328 CARDIAC PACEMAKER INSERTION 34 0.0057
329 ENURESIS 23 0.0057
330 FOOT DEFORMITY 63 0.0057
331 MENTAL IMPAIRMENT 137 0.0056
332 PRODUCT COLOUR ISSUE 29 0.0056
333 UPPER LIMB FRACTURE 112 0.0056
334 MITRAL VALVE INCOMPETENCE 63 0.0056
335 PRODUCT COMMUNICATION ISSUE 49 0.0055
336 APPLICATION SITE REACTION 39 0.0055
337 PANIC ATTACK 202 0.0055
338 URINARY RETENTION 183 0.0055
339 COORDINATION ABNORMAL 76 0.0054
340 GASTROINTESTINAL SOUNDS ABNORMAL 27 0.0054
341 FEELING ABNORMAL 1303 0.0054
342 BODY HEIGHT DECREASED 58 0.0054
343 ADVERSE DRUG REACTION 484 0.0054
344 PARALYSIS 77 0.0054
345 REFUSAL OF TREATMENT BY PATIENT 35 0.0054
346 MUSCULOSKELETAL DISORDER 101 0.0053
347 LIMB DISCOMFORT 164 0.0053
348 NERVOUSNESS 276 0.0053
349 INSOMNIA 1401 0.0053
350 HYPOTENSION 1053 0.0052
351 SPINAL COMPRESSION FRACTURE 43 0.0052
352 SPINAL FUSION SURGERY 21 0.0052
353 SARS-COV-2 TEST POSITIVE 68 0.0051
354 SHOULDER OPERATION 22 0.0051
355 DEPRESSED MOOD 272 0.0051
356 FEAR 138 0.0051
357 DIZZINESS 2557 0.0051
358 WEIGHT DECREASED 1429 0.0051
359 INGUINAL HERNIA 31 0.0051
360 ANXIETY 1444 0.0051
361 PRODUCT AVAILABILITY ISSUE 115 0.0050
362 SYNCOPE 504 0.0050
363 ABDOMINAL TENDERNESS 25 0.0050
364 SUBDURAL HAEMATOMA 72 0.0050
365 ABASIA 124 0.0050
366 GENERAL PHYSICAL CONDITION ABNORMAL 34 0.0050
367 GENERAL PHYSICAL HEALTH DETERIORATION 578 0.0050
368 ASTHENIA 1878 0.0050
369 TREATMENT NONCOMPLIANCE 271 0.0049
370 CONCUSSION 38 0.0049
371 SPINAL COLUMN STENOSIS 23 0.0049
372 HYPERNATRAEMIA 24 0.0048
373 TRANSIENT ISCHAEMIC ATTACK 162 0.0048
374 APATHY 70 0.0048
375 DRUG EFFECT DECREASED 258 0.0048
376 SPINAL OSTEOARTHRITIS 42 0.0048
377 HAEMORRHAGIC ANAEMIA 21 0.0048
378 OROPHARYNGEAL DISCOMFORT 43 0.0048
379 INFUSION SITE PAIN 61 0.0047
380 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 221 0.0047
381 HYPERTONIA 27 0.0047
382 EUPHORIC MOOD 48 0.0047
383 MUSCLE STRAIN 40 0.0046
384 PRODUCT DOSE OMISSION 301 0.0046
385 TROPONIN INCREASED 35 0.0046
386 RETCHING 97 0.0045
387 DECREASED ACTIVITY 49 0.0045
388 JOINT DISLOCATION 48 0.0045
389 SCOLIOSIS 28 0.0045
390 HYPERHIDROSIS 582 0.0045
391 CONDITION AGGRAVATED 1372 0.0045
392 HIP ARTHROPLASTY 69 0.0045
393 DYSPHONIA 263 0.0045
394 DISTURBANCE IN ATTENTION 242 0.0045
395 THERAPEUTIC RESPONSE UNEXPECTED 200 0.0045
396 MUSCULAR WEAKNESS 506 0.0044
397 BLEPHAROSPASM 28 0.0044
398 DRY THROAT 45 0.0044
399 EYE MOVEMENT DISORDER 30 0.0044
400 ANGER 148 0.0044
401 DEHYDRATION 579 0.0043
402 PRODUCT SUBSTITUTION ISSUE 249 0.0043
403 POLLAKIURIA 179 0.0043
404 ECONOMIC PROBLEM 65 0.0043
405 LIMB INJURY 115 0.0042
406 FEMUR FRACTURE 131 0.0042
407 APPETITE DISORDER 28 0.0042
408 IMPAIRED DRIVING ABILITY 48 0.0042
409 GRANULOCYTOPENIA 24 0.0042
410 DRUG INTERACTION 668 0.0042
411 CARDIAC VALVE DISEASE 24 0.0042
412 SOCIAL AVOIDANT BEHAVIOUR 24 0.0041
413 DEFAECATION URGENCY 29 0.0041
414 DEPRESSED LEVEL OF CONSCIOUSNESS 163 0.0041
415 CYSTITIS 131 0.0041
416 UNDERDOSE 299 0.0041
417 HERNIA 79 0.0041
418 POST PROCEDURAL COMPLICATION 78 0.0041
419 SPINAL FRACTURE 81 0.0040
420 MOOD ALTERED 110 0.0040
421 CHROMATURIA 91 0.0040
422 DEVICE RELATED INFECTION 62 0.0040
423 JOINT INJURY 86 0.0040
424 COUGH 1126 0.0040
425 COLITIS MICROSCOPIC 19 0.0040
426 TONGUE DISORDER 29 0.0040
427 PERIPHERAL SWELLING 615 0.0040
428 PRESYNCOPE 97 0.0040
429 BACK INJURY 43 0.0040
430 ANOSMIA 57 0.0039
431 ALTERED STATE OF CONSCIOUSNESS 85 0.0039
432 MENTAL DISORDER 170 0.0039
433 CACHEXIA 20 0.0039
434 CATARACT OPERATION 23 0.0039
435 SENSORY DISTURBANCE 62 0.0039
436 PERIPHERAL COLDNESS 53 0.0039
437 COLD SWEAT 68 0.0039
438 LOWER LIMB FRACTURE 74 0.0038
439 SUBARACHNOID HAEMORRHAGE 39 0.0038
440 INTESTINAL OBSTRUCTION 144 0.0038
441 PRODUCT DISPENSING ERROR 83 0.0038
442 PROCEDURAL COMPLICATION 29 0.0038
443 PHARMACEUTICAL PRODUCT COMPLAINT 98 0.0038
444 BRAIN FOG 59 0.0038
445 ATRIAL FLUTTER 30 0.0038
446 ENCEPHALOPATHY 92 0.0037
447 FORMICATION 26 0.0037
448 BLOOD SODIUM DECREASED 70 0.0037
449 MUSCLE DISORDER 30 0.0037
450 TOOTH EXTRACTION 46 0.0037
451 CEREBRAL ISCHAEMIA 19 0.0037
452 DUODENAL ULCER 26 0.0037
453 HOSPITALISATION 566 0.0037
454 MUSCLE SPASMS 673 0.0037
455 PSYCHIATRIC SYMPTOM 27 0.0037
456 MALIGNANT MELANOMA 49 0.0037
457 PHOTOPSIA 23 0.0036
458 FACIAL PARALYSIS 31 0.0036
459 ACTIVITIES OF DAILY LIVING IMPAIRED 72 0.0036
460 WEIGHT FLUCTUATION 38 0.0036
461 ILEUS 45 0.0036
462 RESPIRATORY RATE INCREASED 32 0.0036
463 WOUND INFECTION 39 0.0036
464 INCORRECT DOSE ADMINISTERED BY DEVICE 93 0.0035
465 BLOOD IRON DECREASED 42 0.0035
466 ATAXIA 42 0.0035
467 HYPERLIPIDAEMIA 42 0.0035
468 SEDATION 92 0.0035
469 SCIATICA 56 0.0035
470 SUDDEN DEATH 37 0.0035
471 CARDIOMEGALY 43 0.0035
472 ANURIA 30 0.0035
473 RESPIRATION ABNORMAL 24 0.0035
474 CORONAVIRUS INFECTION 23 0.0035
475 DEATH 2993 0.0035
476 DEPRESSION 784 0.0034
477 DENTAL CARIES 38 0.0034
478 QUALITY OF LIFE DECREASED 46 0.0034
479 SURGERY 200 0.0034
480 CEREBRAL HAEMORRHAGE 122 0.0034
481 BLOOD PRESSURE INCREASED 521 0.0034
482 BLOOD UREA INCREASED 57 0.0034
483 CONTUSION 327 0.0034
484 PULMONARY THROMBOSIS 37 0.0034
485 CLOSTRIDIUM DIFFICILE INFECTION 74 0.0034
486 DIVERTICULUM 24 0.0034
487 SLEEP APNOEA SYNDROME 64 0.0034
488 TARDIVE DYSKINESIA 94 0.0033
489 INABILITY TO AFFORD MEDICATION 33 0.0033
490 MUSCLE ATROPHY 42 0.0033
491 PEMPHIGOID 25 0.0033
492 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 34 0.0033
493 AFFECTIVE DISORDER 26 0.0033
494 EXTRAPYRAMIDAL DISORDER 82 0.0033
495 MALAISE 1448 0.0033
496 OEDEMA PERIPHERAL 401 0.0033
497 SEROTONIN SYNDROME 63 0.0033
498 GLAUCOMA 63 0.0033
499 WHITE BLOOD CELL COUNT INCREASED 125 0.0033
500 EYELID PTOSIS 33 0.0032
501 SEIZURE 374 0.0032
502 ATRIAL FIBRILLATION 315 0.0032
503 ABNORMAL LOSS OF WEIGHT 22 0.0032
504 CATARACT 192 0.0032
505 ACUTE RESPIRATORY FAILURE 62 0.0032
506 PRODUCT DOSE OMISSION ISSUE 946 0.0032
507 SEPSIS 358 0.0032
508 DRUG INTOLERANCE 309 0.0032
509 ROTATOR CUFF SYNDROME 41 0.0032
510 NEPHROLITHIASIS 146 0.0032
511 INJECTION SITE NODULE 35 0.0032
512 HIATUS HERNIA 41 0.0032
513 ORAL DISCOMFORT 44 0.0032
514 CRYING 115 0.0032
515 AKATHISIA 43 0.0031
516 DRUG INEFFECTIVE 4142 0.0031
517 CARPAL TUNNEL SYNDROME 44 0.0031
518 DECREASED APPETITE 729 0.0031
519 AMNESIA 204 0.0031
520 BLOOD POTASSIUM DECREASED 94 0.0031
521 INTESTINAL PERFORATION 35 0.0031
522 PYELONEPHRITIS 27 0.0031
523 SECRETION DISCHARGE 39 0.0031
524 EMOTIONAL DISORDER 96 0.0031
525 SENSORY LOSS 25 0.0031
526 PNEUMONIA 1005 0.0031
527 THROAT IRRITATION 139 0.0031
528 ADVERSE REACTION 41 0.0031
529 SMALL INTESTINAL OBSTRUCTION 38 0.0031
530 PALLOR 84 0.0031
531 APNOEA 24 0.0031
532 SPINAL DISORDER 29 0.0031
533 HYPOTHERMIA 31 0.0031
534 NAUSEA 2419 0.0031
535 KNEE ARTHROPLASTY 64 0.0030
536 NERVE COMPRESSION 28 0.0030
537 ILL-DEFINED DISORDER 183 0.0030
538 MAJOR DEPRESSION 22 0.0030
539 HEART RATE DECREASED 105 0.0030
540 SEXUAL DYSFUNCTION 35 0.0030
541 EXPIRED PRODUCT ADMINISTERED 99 0.0030
542 INTERNAL HAEMORRHAGE 34 0.0030
543 COLITIS ISCHAEMIC 20 0.0030
544 COVID-19 PNEUMONIA 35 0.0030
545 ACCIDENT 35 0.0029
546 OSTEOMYELITIS 53 0.0029
547 HICCUPS 24 0.0029
548 IMPAIRED QUALITY OF LIFE 42 0.0029
549 FEELING HOT 178 0.0029
550 ATELECTASIS 28 0.0029
551 HYPERTHERMIA 22 0.0029
552 SENSATION OF FOREIGN BODY 24 0.0028
553 RESPIRATORY DISORDER 85 0.0028
554 LOWER GASTROINTESTINAL HAEMORRHAGE 21 0.0028
555 JOINT RANGE OF MOTION DECREASED 38 0.0028
556 HEART RATE IRREGULAR 64 0.0028
557 BACK DISORDER 46 0.0028
558 MYOCARDIAL ISCHAEMIA 32 0.0028
559 ABDOMINAL DISCOMFORT 471 0.0028
560 VITAMIN D DECREASED 24 0.0028
561 ELECTROCARDIOGRAM ABNORMAL 22 0.0028
562 KIDNEY INFECTION 55 0.0028
563 PRODUCT SUPPLY ISSUE 20 0.0028
564 PNEUMOTHORAX 44 0.0028
565 HAEMATOCRIT DECREASED 55 0.0028
566 FAECES DISCOLOURED 60 0.0028
567 FEELING COLD 77 0.0028
568 HYPOACUSIS 119 0.0028
569 AORTIC ANEURYSM 21 0.0028
570 BIPOLAR DISORDER 30 0.0028
571 POLYNEUROPATHY 33 0.0028
572 SCRATCH 29 0.0027
573 INTERNATIONAL NORMALISED RATIO INCREASED 78 0.0027
574 NEUTROPHIL COUNT INCREASED 28 0.0027
575 RENAL FAILURE CHRONIC 21 0.0027
576 SUICIDAL IDEATION 249 0.0027
577 IMPAIRED GASTRIC EMPTYING 37 0.0027
578 ANKLE FRACTURE 42 0.0027
579 HYPOTONIA 27 0.0027
580 HYPERTENSIVE CRISIS 30 0.0027
581 DYSURIA 99 0.0027
582 BLOOD URINE PRESENT 51 0.0027
583 CEREBROVASCULAR ACCIDENT 454 0.0027
584 PRODUCT ADMINISTRATION ERROR 54 0.0027
585 HYDRONEPHROSIS 20 0.0027
586 BLOOD MAGNESIUM DECREASED 23 0.0027
587 CARDIAC MURMUR 23 0.0027
588 DEVICE DEFECTIVE 46 0.0027
589 CLOSTRIDIUM DIFFICILE COLITIS 28 0.0026
590 ULCER 42 0.0026
591 ANOREXIA 34 0.0026
592 TOOTH FRACTURE 29 0.0026
593 FATIGUE 2044 0.0026
594 PROSTATIC SPECIFIC ANTIGEN INCREASED 36 0.0026
595 NECK PAIN 146 0.0026
596 MYOCLONUS 31 0.0026
597 PRODUCT DISTRIBUTION ISSUE 24 0.0026
598 ACCIDENTAL UNDERDOSE 37 0.0026
599 GASTRIC DISORDER 88 0.0026
600 INTERVERTEBRAL DISC PROTRUSION 56 0.0026
601 CELLULITIS 129 0.0026
602 NEURALGIA 62 0.0025
603 BLOOD CREATINE PHOSPHOKINASE INCREASED 73 0.0025
604 HYPERTENSION 537 0.0025
605 OXYGEN SATURATION DECREASED 142 0.0025
606 DISCOMFORT 154 0.0025
607 MUSCULOSKELETAL CHEST PAIN 39 0.0025
608 URINE OUTPUT DECREASED 22 0.0025
609 THROAT TIGHTNESS 68 0.0025
610 APHONIA 35 0.0025
611 AFFECT LABILITY 24 0.0025
612 BRAIN INJURY 25 0.0025
613 STENT PLACEMENT 20 0.0025
614 VERTIGO 151 0.0025
615 OSTEOARTHRITIS 105 0.0025
616 ABDOMINAL DISTENSION 256 0.0024
617 DEVICE DELIVERY SYSTEM ISSUE 67 0.0024
618 DEVICE USE ERROR 85 0.0024
619 VITREOUS FLOATERS 24 0.0024
620 CARDIAC FAILURE CONGESTIVE 196 0.0024
621 KNEE OPERATION 24 0.0024
622 IRRITABILITY 146 0.0024
623 LIGAMENT SPRAIN 24 0.0024
624 GASTRIC ULCER 46 0.0024
625 ACUTE MYOCARDIAL INFARCTION 71 0.0024
626 AGEUSIA 60 0.0024
627 LOCALISED INFECTION 58 0.0024
628 INCREASED TENDENCY TO BRUISE 22 0.0024
629 GRIP STRENGTH DECREASED 21 0.0024
630 SINUS BRADYCARDIA 23 0.0024
631 CHOLELITHIASIS 78 0.0024
632 ILLNESS 245 0.0024
633 INTERVERTEBRAL DISC DEGENERATION 22 0.0024
634 NODULE 31 0.0024
635 RHABDOMYOLYSIS 99 0.0024
636 ROAD TRAFFIC ACCIDENT 99 0.0024
637 GASTROINTESTINAL PAIN 26 0.0024
638 HEMIPARESIS 40 0.0024
639 THERAPY NON-RESPONDER 106 0.0024
640 WRONG DRUG ADMINISTERED 21 0.0024
641 CYANOSIS 37 0.0024
642 GASTROINTESTINAL INFECTION 21 0.0023
643 MYDRIASIS 30 0.0023
644 SQUAMOUS CELL CARCINOMA 22 0.0023
645 ASPHYXIA 19 0.0023
646 COVID-19 408 0.0023
647 SKIN INFECTION 26 0.0023
648 GASTROINTESTINAL DISORDER 207 0.0023
649 PRODUCT PRESCRIBING ERROR 55 0.0023
650 VISUAL IMPAIRMENT 286 0.0023
651 PRODUCT USE ISSUE 431 0.0023
652 VISION BLURRED 314 0.0023
653 PAIN IN EXTREMITY 666 0.0023
654 THERAPEUTIC RESPONSE DECREASED 137 0.0023
655 HYPONATRAEMIA 127 0.0023
656 WOUND 63 0.0023
657 INCREASED APPETITE 43 0.0022
658 RESPIRATORY FAILURE 164 0.0022
659 PHARYNGEAL SWELLING 22 0.0022
660 RESPIRATORY DISTRESS 62 0.0022
661 DYSPNOEA 1271 0.0022
662 INTENTIONAL DOSE OMISSION 64 0.0022
663 STAPHYLOCOCCAL INFECTION 74 0.0022
664 PRODUCTIVE COUGH 107 0.0022
665 HYPOMAGNESAEMIA 31 0.0022
666 FRACTURE 42 0.0022
667 HYPOAESTHESIA 332 0.0022
668 BLOOD POTASSIUM INCREASED 36 0.0022
669 BLOOD PRESSURE SYSTOLIC INCREASED 43 0.0022
670 FLATULENCE 125 0.0022
671 EXTRA DOSE ADMINISTERED 89 0.0022
672 MOOD SWINGS 70 0.0022
673 DYSPEPSIA 216 0.0022
674 MEDICATION ERROR 122 0.0022
675 WRONG TECHNIQUE IN DRUG USAGE PROCESS 79 0.0022
676 BLOOD ALKALINE PHOSPHATASE INCREASED 54 0.0022
677 HAEMATOMA 56 0.0022
678 GASTROENTERITIS VIRAL 39 0.0022
679 APPLICATION SITE PRURITUS 49 0.0022
680 RHINORRHOEA 139 0.0021
681 BACK PAIN 499 0.0021
682 THERAPY CHANGE 21 0.0021
683 HYPOXIA 75 0.0021
684 GASTRITIS 56 0.0021
685 PROCEDURAL PAIN 59 0.0021
686 PULMONARY OEDEMA 95 0.0021
687 VENTRICULAR EXTRASYSTOLES 22 0.0021
688 GASTROINTESTINAL HAEMORRHAGE 177 0.0021
689 PULMONARY HYPERTENSION 44 0.0021
690 SKIN DISCOLOURATION 97 0.0021
691 HAEMATURIA 72 0.0021
692 JOINT STIFFNESS 55 0.0021
693 VOMITING 984 0.0021
694 SKIN CANCER 45 0.0021
695 PRODUCT DOSE OMISSION IN ERROR 59 0.0021
696 PRODUCT PRESCRIBING ISSUE 45 0.0021
697 ABDOMINAL PAIN 479 0.0021
698 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 371 0.0021
699 FOOT FRACTURE 39 0.0021
700 DIVERTICULITIS 57 0.0021
701 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 107 0.0020
702 TOOTH INFECTION 27 0.0020
703 CORONARY ARTERY OCCLUSION 28 0.0020
704 BRADYCARDIA 108 0.0020
705 LACRIMATION INCREASED 61 0.0020
706 PULMONARY MASS 30 0.0020
707 MACULAR DEGENERATION 24 0.0020
708 INFECTION 290 0.0020
709 RECTAL HAEMORRHAGE 86 0.0020
710 HAEMORRHOIDS 39 0.0020
711 MELAENA 44 0.0020
712 HEART RATE INCREASED 198 0.0020
713 NEUROPATHY PERIPHERAL 190 0.0020
714 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 403 0.0020
715 DISEASE PROGRESSION 235 0.0020
716 SEASONAL ALLERGY 28 0.0020
717 EYE DISORDER 65 0.0020
718 PULMONARY CONGESTION 26 0.0020
719 ORAL PAIN 44 0.0020
720 TOOTH ABSCESS 20 0.0020
721 CHEST PAIN 361 0.0019
722 CORONARY ARTERY DISEASE 59 0.0019
723 STATUS EPILEPTICUS 22 0.0019
724 HAEMORRHAGE INTRACRANIAL 29 0.0019
725 PLEURAL EFFUSION 118 0.0019
726 HOT FLUSH 146 0.0019
727 SKIN ULCER 50 0.0019
728 CHOLECYSTITIS 23 0.0019
729 BACTERIAL INFECTION 36 0.0019
730 FLUID RETENTION 97 0.0019
731 CHEST DISCOMFORT 195 0.0019
732 DRUG DISPENSING ERROR 29 0.0019
733 INTENTIONAL PRODUCT USE ISSUE 165 0.0019
734 ABDOMINAL PAIN UPPER 387 0.0019
735 COLON CANCER 28 0.0019
736 LEUKOCYTOSIS 34 0.0019
737 BRONCHITIS 139 0.0019
738 CARDIAC ARREST 155 0.0019
739 MUSCLE SPASTICITY 23 0.0019
740 HAEMOGLOBIN DECREASED 191 0.0019
741 MUSCULOSKELETAL DISCOMFORT 32 0.0019
742 WITHDRAWAL SYNDROME 78 0.0019
743 GASTROOESOPHAGEAL REFLUX DISEASE 149 0.0018
744 COMA 88 0.0018
745 RESPIRATORY TRACT INFECTION 48 0.0018
746 PLATELET COUNT INCREASED 24 0.0018
747 APPLICATION SITE ERYTHEMA 48 0.0018
748 INCORRECT DOSE ADMINISTERED 417 0.0018
749 TASTE DISORDER 37 0.0018
750 ABSCESS 29 0.0018
751 HYPOGLYCAEMIA 88 0.0018
752 MUSCULOSKELETAL PAIN 95 0.0018
753 LIP SWELLING 60 0.0018
754 PALPITATIONS 211 0.0018
755 HYPOAESTHESIA ORAL 27 0.0018
756 TENDON RUPTURE 22 0.0018
757 SUICIDE ATTEMPT 108 0.0018
758 EOSINOPHILIA 31 0.0018
759 NIGHT SWEATS 57 0.0018
760 CARDIAC DISORDER 165 0.0018
761 RESPIRATORY TRACT CONGESTION 28 0.0018
762 CARDIOMYOPATHY 26 0.0018
763 PULMONARY EMBOLISM 167 0.0018
764 PARAESTHESIA 276 0.0018
765 THYROID DISORDER 27 0.0017
766 CONVULSION 100 0.0017
767 BURSITIS 21 0.0017
768 NERVOUS SYSTEM DISORDER 54 0.0017
769 BODY TEMPERATURE INCREASED 35 0.0017
770 COLITIS 65 0.0017
771 THERAPY INTERRUPTED 122 0.0017
772 ARTHRITIS 134 0.0017
773 ABDOMINAL PAIN LOWER 43 0.0017
774 SWOLLEN TONGUE 53 0.0017
775 RENAL FAILURE ACUTE 72 0.0017
776 PAIN 1041 0.0017
777 TACHYPNOEA 23 0.0017
778 RED BLOOD CELL COUNT DECREASED 48 0.0017
779 CARDIAC FAILURE 134 0.0017
780 THROMBOSIS 134 0.0017
781 HAEMATEMESIS 42 0.0017
782 LUNG DISORDER 81 0.0017
783 JOINT SWELLING 197 0.0016
784 DRUG LEVEL INCREASED 27 0.0016
785 BLOOD CHOLESTEROL INCREASED 76 0.0016
786 DRUG ADMINISTRATION ERROR 50 0.0016
787 INJURY 114 0.0016
788 RENAL FAILURE 215 0.0016
789 WEIGHT INCREASED 362 0.0016
790 DYSGEUSIA 120 0.0016
791 OVERDOSE 348 0.0016
792 INTENTIONAL PRODUCT MISUSE 141 0.0016
793 BURNING SENSATION 111 0.0016
794 MYOCARDIAL INFARCTION 276 0.0016
795 TINNITUS 72 0.0016
796 THIRST 28 0.0016
797 ARRHYTHMIA 74 0.0016
798 GOUT 28 0.0016
799 COAGULOPATHY 26 0.0016
800 RESPIRATORY ARREST 43 0.0016
801 ERUCTATION 30 0.0015
802 UPPER GASTROINTESTINAL HAEMORRHAGE 26 0.0015
803 BASAL CELL CARCINOMA 24 0.0015
804 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 109 0.0015
805 OEDEMA 83 0.0015
806 ELECTROCARDIOGRAM QT PROLONGED 55 0.0015
807 ORAL CANDIDIASIS 20 0.0015
808 LOWER RESPIRATORY TRACT INFECTION 69 0.0015
809 BLOOD CREATININE INCREASED 99 0.0015
810 INFLUENZA 169 0.0015
811 VENTRICULAR TACHYCARDIA 25 0.0015
812 GALLBLADDER DISORDER 27 0.0015
813 DRUG PRESCRIBING ERROR 29 0.0015
814 HEADACHE 945 0.0015
815 EMOTIONAL DISTRESS 182 0.0015
816 BLINDNESS UNILATERAL 21 0.0015
817 TOOTH DISORDER 33 0.0015
818 MYALGIA 252 0.0015
819 DRUG TOXICITY 20 0.0015
820 DISABILITY 29 0.0015
821 IMPAIRED HEALING 48 0.0015
822 DEEP VEIN THROMBOSIS 95 0.0015
823 ISCHAEMIC STROKE 26 0.0015
824 PARAESTHESIA ORAL 21 0.0015
825 ACCIDENTAL OVERDOSE 53 0.0014
826 PAIN IN JAW 41 0.0014
827 FUNGAL INFECTION 48 0.0014
828 DRUG DOSE OMISSION 237 0.0014
829 CEREBRAL INFARCTION 35 0.0014
830 CANDIDA INFECTION 24 0.0014
831 UPPER RESPIRATORY TRACT INFECTION 65 0.0014
832 EPILEPSY 43 0.0014
833 FREQUENT BOWEL MOVEMENTS 38 0.0014
834 ARTHROPATHY 78 0.0014
835 ERECTILE DYSFUNCTION 36 0.0014
836 NASAL CONGESTION 82 0.0014
837 CHILLS 163 0.0014
838 GENERALISED TONIC-CLONIC SEIZURE 23 0.0014
839 BLISTER 78 0.0014
840 INTENTIONAL SELF-INJURY 28 0.0014
841 PERICARDIAL EFFUSION 32 0.0014
842 APPLICATION SITE RASH 19 0.0014
843 HYPERKALAEMIA 48 0.0014
844 OSTEOPOROSIS 56 0.0014
845 CHOLESTASIS 26 0.0014
846 ANAEMIA 258 0.0014
847 TOOTH LOSS 28 0.0013
848 DEAFNESS 35 0.0013
849 DIARRHOEA 859 0.0013
850 PHOTOPHOBIA 25 0.0013
851 FLUSHING 135 0.0013
852 TOOTHACHE 24 0.0013
853 HYPOKALAEMIA 61 0.0013
854 SINUS DISORDER 26 0.0013
855 BLOOD GLUCOSE DECREASED 63 0.0013
856 SWELLING 122 0.0013
857 PULMONARY FIBROSIS 25 0.0013
858 JAUNDICE 35 0.0013
859 SNEEZING 29 0.0013
860 VIRAL INFECTION 43 0.0013
861 RENAL DISORDER 60 0.0013
862 DRY EYE 64 0.0013
863 SKIN LESION 35 0.0013
864 PYREXIA 440 0.0013
865 HYPOCALCAEMIA 24 0.0013
866 GAMMA-GLUTAMYLTRANSFERASE INCREASED 28 0.0013
867 BONE DISORDER 23 0.0013
868 HERPES ZOSTER 72 0.0013
869 SWELLING FACE 81 0.0012
870 EAR INFECTION 33 0.0012
871 SKIN DISORDER 41 0.0012
872 CARDIO-RESPIRATORY ARREST 51 0.0012
873 MULTIPLE FRACTURES 20 0.0012
874 EPISTAXIS 91 0.0012
875 OROPHARYNGEAL PAIN 112 0.0012
876 HYPERGLYCAEMIA 44 0.0012
877 ARTHRALGIA 501 0.0012
878 BLOOD LACTATE DEHYDROGENASE INCREASED 19 0.0012
879 DYSPNOEA EXERTIONAL 45 0.0012
880 NEOPLASM MALIGNANT 79 0.0012
881 EAR PAIN 23 0.0012
882 RASH PRURITIC 64 0.0012
883 CIRCULATORY COLLAPSE 20 0.0012
884 LACTIC ACIDOSIS 38 0.0012
885 TACHYCARDIA 104 0.0012
886 GLOSSODYNIA 26 0.0012
887 PERITONITIS 24 0.0012
888 INCORRECT PRODUCT ADMINISTRATION DURATION 25 0.0012
889 LYMPHOCYTE COUNT DECREASED 20 0.0011
890 ACUTE KIDNEY INJURY 173 0.0011
891 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 62 0.0011
892 SEPTIC SHOCK 49 0.0011
893 SKIN IRRITATION 51 0.0011
894 HAEMATOCHEZIA 61 0.0011
895 C-REACTIVE PROTEIN INCREASED 40 0.0011
896 ASPARTATE AMINOTRANSFERASE INCREASED 58 0.0011
897 DIABETES MELLITUS 83 0.0011
898 ANGINA PECTORIS 31 0.0011
899 WHEEZING 64 0.0011
900 INTENTIONAL OVERDOSE 69 0.0011
901 HAEMOPTYSIS 30 0.0011
902 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
903 ERYTHEMA 221 0.0011
904 NASOPHARYNGITIS 197 0.0011
905 HYPOTHYROIDISM 34 0.0011
906 HYPERSENSITIVITY 197 0.0011
907 BLINDNESS 43 0.0011
908 RASH ERYTHEMATOUS 50 0.0010
909 PANCREATITIS 55 0.0010
910 RASH MACULAR 36 0.0010
911 PRODUCT USE IN UNAPPROVED INDICATION 252 0.0010
912 INJECTION SITE MASS 37 0.0010
913 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 33 0.0010
914 PRURITUS GENERALISED 21 0.0010
915 VISUAL ACUITY REDUCED 32 0.0010
916 HAEMORRHAGE 99 0.0009
917 PRODUCT QUALITY ISSUE 127 0.0009
918 PANCREATITIS ACUTE 21 0.0009
919 RASH GENERALISED 24 0.0009
920 RASH 399 0.0009
921 DEVICE EXPULSION 58 0.0009
922 CONTRAINDICATED PRODUCT ADMINISTERED 27 0.0009
923 INJECTION SITE BRUISING 71 0.0009
924 PNEUMONITIS 24 0.0009
925 LABORATORY TEST ABNORMAL 26 0.0009
926 INJECTION SITE PRURITUS 59 0.0009
927 OFF LABEL USE 759 0.0009
928 DRUG ABUSE 72 0.0009
929 INFLAMMATION 44 0.0009
930 EYE PAIN 48 0.0008
931 MULTIPLE ORGAN DYSFUNCTION SYNDROME 24 0.0008
932 PRODUCT STORAGE ERROR 74 0.0008
933 OCULAR HYPERAEMIA 39 0.0008
934 BONE PAIN 48 0.0008
935 INCORRECT DRUG ADMINISTRATION DURATION 23 0.0008
936 TYPE 2 DIABETES MELLITUS 27 0.0008
937 SINUSITIS 82 0.0008
938 DEVICE MALFUNCTION 56 0.0008
939 PROSTATE CANCER 64 0.0008
940 BLOOD BILIRUBIN INCREASED 21 0.0008
941 PRURITUS 297 0.0008
942 LEUKOPENIA 38 0.0008
943 STOMATITIS 46 0.0008
944 METABOLIC ACIDOSIS 24 0.0007
945 INJECTION SITE ERYTHEMA 93 0.0007
946 ALANINE AMINOTRANSFERASE INCREASED 46 0.0007
947 CARDIOVASCULAR DISORDER 19 0.0007
948 LUNG NEOPLASM MALIGNANT 30 0.0007
949 EYE IRRITATION 42 0.0007
950 PRODUCT ADHESION ISSUE 26 0.0007
951 INCORRECT ROUTE OF DRUG ADMINISTRATION 26 0.0007
952 INFLUENZA LIKE ILLNESS 59 0.0007
953 ASTHMA 80 0.0007
954 DRUG WITHDRAWAL SYNDROME 62 0.0007
955 THROMBOCYTOPENIA 77 0.0007
956 CHRONIC KIDNEY DISEASE 52 0.0007
957 RENAL IMPAIRMENT 57 0.0007
958 SKIN EXFOLIATION 57 0.0007
959 NO ADVERSE EVENT 122 0.0007
960 PLATELET COUNT DECREASED 69 0.0006
961 WHITE BLOOD CELL COUNT DECREASED 70 0.0006
962 COMPLETED SUICIDE 53 0.0006
963 EYE PRURITUS 21 0.0006
964 BLOOD GLUCOSE INCREASED 116 0.0006
965 NEUTROPHIL COUNT DECREASED 25 0.0006
966 LIVER DISORDER 27 0.0006
967 ALOPECIA 118 0.0006
968 LYMPHADENOPATHY 21 0.0006
969 EYE SWELLING 22 0.0006
970 MIGRAINE 56 0.0006
971 HEPATIC ENZYME INCREASED 39 0.0006
972 URTICARIA 90 0.0005
973 INJECTION SITE HAEMORRHAGE 42 0.0005
974 TOXICITY TO VARIOUS AGENTS 84 0.0005
975 ECZEMA 26 0.0005
976 NEUTROPENIA 66 0.0005
977 DISEASE RECURRENCE 23 0.0005
978 PANCYTOPENIA 26 0.0005
979 INJECTION SITE REACTION 32 0.0005
980 DRY SKIN 61 0.0005
981 INJECTION SITE SWELLING 35 0.0005
982 DEPENDENCE 25 0.0005
983 ANGIOEDEMA 20 0.0005
984 MULTIPLE SCLEROSIS RELAPSE 29 0.0004
985 SKIN BURNING SENSATION 25 0.0003
986 PSORIASIS 42 0.0003
987 DRUG DEPENDENCE 51 0.0003
988 INJECTION SITE PAIN 93 0.0003
989 TREATMENT FAILURE 25 0.0003
990 BREAST CANCER 25 0.0003
991 RHEUMATOID ARTHRITIS 29 0.0003
992 MALIGNANT NEOPLASM PROGRESSION 26 0.0003
993 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002